Growth Metrics

Galectin Therapeutics (GALT) Assets Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 Galectin Therapeutics 165.77 Mn 151.67 Mn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -7.98%
Dec 31, 2025 -2.82%
Sep 30, 2025 -10.45%
Jun 30, 2025 -15.53%
Mar 31, 2025 -34.31%
Dec 31, 2024 -25.21%
Sep 30, 2024 -8.68%
Jun 30, 2024 -6.10%
Mar 31, 2024 4.18%
Dec 31, 2023 -1.60%
Sep 30, 2023 -13.34%
Jun 30, 2023 -21.38%
Mar 31, 2023 -22.89%
Dec 31, 2022 -23.99%
Sep 30, 2022 -29.33%
Jun 30, 2022 -21.25%
Mar 31, 2022 62.53%
Dec 31, 2021 66.84%
Sep 30, 2021 53.02%
Jun 30, 2021 43.90%
Mar 31, 2021 66.83%
Dec 31, 2020 92.32%
Sep 30, 2020 69.35%
Jun 30, 2020 64.22%
Mar 31, 2020 46.61%
Dec 31, 2019 45.31%
Sep 30, 2019 46.59%
Jun 30, 2019 42.69%
Mar 31, 2019 -29.96%
Dec 31, 2018 -30.13%
Sep 30, 2018 -20.98%
Jun 30, 2018 -25.10%
Mar 31, 2018 -45.21%
Dec 31, 2017 -48.05%
Sep 30, 2017 -39.28%
Jun 30, 2017 -35.39%
Mar 31, 2017 -27.61%
Dec 31, 2016 13.82%
Sep 30, 2016 18.12%
Jun 30, 2016 51.72%
Mar 31, 2016 46.85%
Dec 31, 2015 40.31%
Sep 30, 2015 24.33%
Jun 30, 2015 26.05%
Mar 31, 2015 24.48%
Dec 31, 2014 64.95%
Sep 30, 2014 56.94%
Jun 30, 2014 61.85%
Dec 31, 2013 19.36%